secwatch.observer — SEC 8-K summary
======================================

Issuer:     PETMED EXPRESS INC (PETS)
CIK:        0001040130
Form:       8-K
Filed at:   2023-07-31T23:59:59+00:00
Accession:  0001040130-23-000049
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PetMed Express Q1 net sales $78.2M (+11.5% YoY); net loss $(0.9)M; declares $0.30 dividend
--------------------------------------------------------------------------------

- Net sales $78.2M, up 11.5% YoY from $70.2M; net loss $(0.9)M ($0.04 diluted loss) vs net income $2.8M ($0.14 EPS) in prior year.
- Adjusted EBITDA $3.3M, down 47% from $6.3M; new customers up 25% YoY (third consecutive quarter).
- Board declared quarterly dividend $0.30/share, payable Aug 18, 2023 to holders of record Aug 14, 2023.
- Acquisition of PetCareRx closed Apr 3, 2023; contributed almost full quarter of consolidated results.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1040130/000104013023000049/0001040130-23-000049-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1040130/000104013023000049/pets-20230731.htm
  HTML page:      https://secwatch.observer/filing/0001040130-23-000049

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer